Preclinical scientific tests counsel that retatrutide could impact being overweight-associated cancer progression. In the research led by Marathe et al., retatrutide-induced weightloss reduced tumor engraftment, delayed tumor onset, and drastically attenuated tumor growth in pancreatic and lung most